To Increase Patient Access
End Brain Cancer Mobile App to download your number one tool for navigating this disease.
YES! I'm Interested.

Are you or a loved one living with


Have you experienced a recurrence?

If so, would you like to participate in a short interview?
YES! I'm Interested.

The Basics

Interviews will be conducted virtually or by phone by Adelphi Values, a research company that works with pharmaceutical companies and patient advocacy organizations to understand various health conditions.

One joint 45-minute interview can be scheduled at your convenience, typically within business hours. Participating caregivers will also be asked to complete a survey after the interview.

Eligible individuals with recurrent GBM and caregivers who complete the joint interview will receive one $100 Visa gift card.

Caregivers will receive one $50 Visa gift card for completing the survey.


Dellann Elliott Mydland
EndBrainCancer Initiative
Tina Nguyen
Adelphi Values


The Details


A joint patient and caregiver interview to share your experiences living with recurrent GBM. Caregivers will also be asked to complete a survey following the interview.


Your perspectives and insights will help to shape future treatments for GBM.


  • 18+
  • Diagnosed with recurrent GBM
  • Have a caregiver willing to participate in a joint interview
YES! I'm Interested.
This is not a medication-related study. No medication will be tested during this study. In order to participate in the study, your diagnosis will need to be confirmed and we may need to contact your clinician. We will ask for your consent to reach out to your clinician prior to contacting them. Your name and contact information will only be accessible to researchers directly involved in this study, and your personal information will not be shared with anyone outside of this study.


Enhancing patient outcomes by expanding FDA-approved treatment modalities and fueling research in the pharma/bio/life sciences, device & diagnostic industries and by closing the existing GAP from initial diagnosis to IMMEDIATE AND EXPANDED ACCESS to specialists, researchers, advanced & innovative treatments, clinical trials and critical care with the ultimate goal of improving patient outcomes through updating and improving WHO & NCCN Guidelines and clinical practices related to Standard of Care for brain cancer patients.

TAX ID:26-2185614
corporate partners
upcoming events
About us
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram